On November 6, 2018, the Board of Directors of ContraVir Pharmaceuticals, Inc. removed acting from Dr. Robert Foster's title as Chief Executive Officer and appointed Dr. Foster as a director of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | +5.88% |
|
+3.85% | -66.67% |
05-21 | Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
1st Jan change | Capi. | |
---|---|---|
-66.67% | 5.91M | |
+20.17% | 126B | |
+24.67% | 118B | |
+23.61% | 27.87B | |
-17.74% | 20.95B | |
-15.73% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |
- Stock Market
- Equities
- HEPA Stock
- News Hepion Pharmaceuticals, Inc.
- ContraVir Pharmaceuticals, Inc. Announces Executive Changes